Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants
- 1 September 1989
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 161 (3), 628-633
- https://doi.org/10.1016/0002-9378(89)90367-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Betamethasone Increases Pulmonary Compliance in Part by Surfactant-Independent Mechanisms in Preterm RabbitsPediatric Research, 1987
- Effects of Maternal Treatment with Corticosteriods, T3, TRH, and Their Combinations on Lung Function of Ventilated Preterm Rabbits with and without Surfactant TreatmentsAmerican Review of Respiratory Disease, 1987
- Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits.JCI Insight, 1987
- DOUBLE-BLIND CONTROLLED TRIAL OF SINGLE-DOSE TREATMENT WITH BOVINE SURFACTANT IN SEVERE HYALINE MEMBRANE DISEASEThe Lancet, 1987
- Prophylactic Treatment of Very Premature Infants with Human SurfactantNew England Journal of Medicine, 1986
- Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trialThe Journal of Pediatrics, 1985
- Dihydrotestosterone Inhibits Fetal Rabbit Pulmonary Surfactant ProductionJCI Insight, 1982
- Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome**See Editorial Comment following this article.American Journal of Obstetrics and Gynecology, 1981